Conference Proceedings

Clinical Activity of Lorlatinib in Patients with ROS1 Advanced Non-Small Cell Lung Cancer: Phase 2 Study Cohort EXP-6

S Ou, A Shaw, G Riely, R Chiari, J Bauman, J Clancy, H Thurm, G Peltz, A Abbattista, B Solomon

Journal of Thoracic Oncology | ELSEVIER SCIENCE INC | Published : 2018

DOI: 10.1016/j.jtho.2018.08.241

Citation metrics

10Web of Science

Keywords

Nsclc
Science & Technology
Lorlatinib
Life Sciences & Biomedicine
Oncology
Respiratory System
Ros1